EUVIMEDEUVIMED entdecken
Fallbericht

Case of buprenorphine-associated central sleep apnea resolving with dose reduction

Vladimir Tchikrizov, Allen C Richert, Saurabh B Bhardwaj

Journal of Opioid Management · 01.07.2022 · 18 (4) · 391-394

DOI: 10.5055/jom.2022.0732 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Opioid Management, online erschienen am 01.07.2022. Verfasst von Vladimir Tchikrizov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi. ORCID: https://orcid.org/0000-0002-2429-…. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders, Sleep Apnea Syndromes, Sleep Apnea, Central. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aside from respiratory suppression in overdose, full opioid agonist agents are known to cause sleep-disordered breathing (SDB). The increasing rates of opioid overdose in the United States have led to increasing use of medication-assisted treatments for opioid use disorders. Dose-dependent increase in SDB has been documented with methadone. There is emerging literature in the form of case reports providing evidence of buprenorphine and buprenorphine–naloxone contributing to sleep apnea. We report an additional case of a female patient developing central sleep apnea during initiation of buprenorphine–naloxone treatment. The condition resolved with dose reduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineOpioid-Related DisordersSleep Apnea SyndromesSleep Apnea, CentralAnalgesics, OpioidBuprenorphine, Naloxone Drug CombinationDrug TaperingFemaleHumansMethadoneNaloxoneNarcotic Antagonists

Substanzen

Analgesics, OpioidBuprenorphine, Naloxone Drug CombinationNarcotic AntagonistsNaloxoneBuprenorphineMethadone

Autor:innen und Institutionen

  • Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi. ORCID: https://orcid.org/0000-0002-2429-7529.
  • Associate Professor, Psychiatry, Division Director, Sleep Medicine, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi.
  • Medical Director, Center for Innovation & Discovery in Addictions (CIDA), Assistant Professor, Department of Psychiatry & Human Behavior, Jackson, Mississippi. ORCID: https://orcid.org/0000-0002-8845-0182.

Zitieren

APA

Tchikrizov, V., Richert, A. C., & Bhardwaj, S. B. (2022). Case of buprenorphine-associated central sleep apnea resolving with dose reduction. Journal of Opioid Management, 18(4), 391-394. https://doi.org/10.5055/jom.2022.0732

Vancouver

Tchikrizov V, Richert AC, Bhardwaj SB. Case of buprenorphine-associated central sleep apnea resolving with dose reduction. Journal of Opioid Management. 2022;18(4):391-394. doi:10.5055/jom.2022.0732

BibTeX
@article{Tchikrizov2022,
  author = {Tchikrizov, Vladimir and Richert, Allen C and Bhardwaj, Saurabh B},
  title = {Case of buprenorphine-associated central sleep apnea resolving with dose reduction},
  journal = {Journal of Opioid Management},
  year = {2022},
  volume = {18},
  number = {4},
  pages = {391--394},
  doi = {10.5055/jom.2022.0732}
}
Kostenlos starten →